About Careers Internship MedBlog Contact us

Impasse With FDA Delays Availability of Libido-Boosting Drugs for Women

by Kathy Jones on December 16, 2013 at 8:33 PM
 Impasse With FDA Delays Availability of Libido-Boosting Drugs for Women

An American company that is looking to develop new drugs to improve sexual desire in women with low libido announced that it needs more time to bring the drug, flibanserin, on to the market after reaching an impasse with the Food and Drug Administration.

Since women's sexual issues are more psychological, than physical, Sprout Pharmaceuticals said that the drug works by acting on brain chemicals connected to mood and appetite, Fox News reported.


Despite of women suffering from hypoactive sexual desire disorder reporting boost in sexual desire and reduction in stress with the drugs, the FDA has twice rejected flibanserin since 2010.

Cindy Whitehead, Sprout's chief operating officer, said that there are now

24 drugs for men for either testosterone replacement or erectile dysfunction, yet there are zero drugs for the most common form of sexual dysfunction in women.

The US firm acquired flibanserin from a German drugmaker in 2011, after they abandoned development of the daily pill following an FDA rejection.

Source: ANI
Font : A-A+



Recommended Readings

Latest Women Health News

Placenta Unravels Anonymous Miscarriages & Stillbirths
More than 90% of previously unexplained pregnancy losses or miscarriages were accurately determined by placental testing.
Predictive Tools for Pregnancy Complications Related to Fetal Growth
Fetal growth restriction impacts around 60,000 infants annually in Europe and the United States.
Urine Ovulation Test may Raise your Chances of Pregnancy
For women under 40, trying to conceive, timing intercourse around the fertile period using a urine ovulation test increases the chances of pregnancy.
Premature Ovary Removal Linked to Accelerated Aging
Oophorectomy's adverse effects raise questions about risk-benefit balance, especially for average ovarian cancer risk women.
Stem Cells Offer Hope for PCOS Root Causes
This study highlights the ovarian resilience achieved through stem cell treatments, providing hope for women struggling with fertility problems related to PCOS.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
Greetings! How can I assist you?MediBot

Impasse With FDA Delays Availability of Libido-Boosting Drugs for Women Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests